When Juul was created, the company’s founders told federal regulators that its product would save lives. Those regulators were eager to believe them. Today, part two in our series on the promise and the peril of vaping.
Guest: Sheila Kaplan, an investigative reporter for The New York Times covering the intersection of money, medicine and politics. For more information on today’s episode, visit nytimes.com/thedaily.